A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) Patients - Related Studies

Home

A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) Patients

This study has been completed.

Study NCT00703391. Last updated on November 3, 2008. Information provided by AstraZeneca

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Lung Diseases
		Pulmonary Disease, Chronic Obstructive

2	More general conditions related to this trial
		Lung Diseases, Obstructive
		Respiratory Tract Diseases

3	Interventions listed in this trial
		AZD9668
		Placebo

4	Sponsors listed in this trial
		AstraZeneca